Skip to main navigation
Skip to content
Top Bar
  • Careers
  • Contact Us
Cyclacel Pharmaceuticals, Inc.
Header Nav - Desktop
  • About Us
    • LEADERSHIP
    • BOARD OF DIRECTORS
  • Our Science
    • OVERVIEW
    • FADRACICLIB
    • CYC140
    • Publications
  • Pipeline
  • News
  • Investors
Cyclacel Pharmaceuticals, Inc.

Investors

Committee Composition

Investor Relations
  • Investor Relations
  • News Releases
  • Presentations & Events
  • Common Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • SEC Filings
  • Corporate Governance
    • Overview
    • Board of Directors
    • Committee Composition
    • Management Team
  • Annual Reports

Committee Composition

Below is a summary of our committee structure and membership information. To read more about any of the committee members click on the names in the chart below.

Audit Committee Compensation and Organization Committee Nominating and Governance Committee Science & Technology Committee
Samuel L. Barker Ph.D. Audit Committee Compensation and Organization Committee Science & Technology Committee
Kenneth M. Ferguson Ph.D. Compensation and Organization Committee Science & Technology Committee
Christopher S. Henney Ph.D., D.Sc. Audit Committee Compensation and Organization Committee Nominating and Governance Committee
Brian Schwartz M.D. Nominating and Governance Committee Science & Technology Committee
Robert J. Spiegel, M.D. Audit Committee Nominating and Governance Committee Science & Technology Committee
Karin L. Walker C.P.A. Audit Committee Nominating and Governance Committee
= Chairperson = Member = Chair of the Board = Vice-Chair of the Board = Financial Expert
Toolkit
Email AlertsRSS FeedsPrint Page
Header Nav - Mobile
  • About Us
    • LEADERSHIP
    • BOARD OF DIRECTORS
  • Our Science
    • OVERVIEW
    • FADRACICLIB
    • CYC140
    • Publications
  • Pipeline
  • News
  • Investors
  • Careers
  • Contact Us
  • Accessibility Statement
  • Privacy Policy
  • Disclaimer
  • Sitemap
Header Nav - Mobile
  • About Us
    • LEADERSHIP
    • BOARD OF DIRECTORS
  • Our Science
    • OVERVIEW
    • FADRACICLIB
    • CYC140
    • Publications
  • Pipeline
  • News
  • Investors
  • Careers
  • Contact Us
  • Accessibility Statement
  • Privacy Policy
  • Disclaimer
  • Sitemap
Cyclacel Pharmaceuticals, Inc. logo

200 Connell Drive #1500
Berkeley Heights, NJ 07922
United States of America

  • E: info@cyclacel.com
  • T: +1 (908) 517 7330
  • F: +1 (866) 271 3466

Sign up for email alerts ยป

Footer Social
  • Twitter
  • LinkedIn
Footer Links
  • Accessibility Statement
  • Privacy Policy
  • Disclaimer
  • Sitemap

© 2023 Cyclacel Pharmaceuticals, Inc.